<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Point mutations at Arg132 of the cytoplasmic <z:chebi fb="0" ids="18009">NADP(+)</z:chebi>-dependent isocitrate dehydrogenase 1 (IDH1) occur frequently in <z:hpo ids='HP_0009733'>gliomas</z:hpo> and result in a gain of function to produce the "oncometabolite" D-2-hydroxyglutarate (D-2HG) </plain></SENT>
<SENT sid="1" pm="."><plain>The mutated IDH1 allele is usually associated with a <z:mp ids='MP_0002169'>wild-type</z:mp> IDH1 allele (heterozygous) in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Here, we identify 2 <z:hpo ids='HP_0009733'>gliomas</z:hpo> that underwent loss of the <z:mp ids='MP_0002169'>wild-type</z:mp> IDH1 allele but retained the mutant IDH1 allele following <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">tumor progression</z:e> from World Health Organization (WHO) grade III anaplastic <z:hpo ids='HP_0009592'>astrocytomas</z:hpo> to WHO grade IV <z:hpo ids='HP_0100843'>glioblastomas</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Intratumoral D-2HG was 14-fold lower in the <z:hpo ids='HP_0100843'>glioblastomas</z:hpo> lacking <z:mp ids='MP_0002169'>wild-type</z:mp> IDH1 than in <z:hpo ids='HP_0100843'>glioblastomas</z:hpo> with heterozygous IDH1 mutations </plain></SENT>
<SENT sid="4" pm="."><plain>To characterize the contribution of <z:mp ids='MP_0002169'>wild-type</z:mp> IDH1 to <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cell D-2HG production, we established an IDH1-mutated <z:hpo ids='HP_0009592'>astrocytoma</z:hpo> (IMA) cell line from a WHO grade III anaplastic <z:hpo ids='HP_0009592'>astrocytoma</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Disruption of the <z:mp ids='MP_0002169'>wild-type</z:mp> IDH1 allele in IMA cells by gene targeting resulted in an 87-fold decrease in cellular D-2HG levels, showing that both <z:mp ids='MP_0002169'>wild-type</z:mp> and mutant IDH1 alleles are required for D-2HG production in <z:hpo ids='HP_0009733'>glioma</z:hpo> cells </plain></SENT>
<SENT sid="6" pm="."><plain>Expression of <z:mp ids='MP_0002169'>wild-type</z:mp> IDH1 was also critical for mutant IDH1-associated D-2HG production in the <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cell line HCT116 </plain></SENT>
<SENT sid="7" pm="."><plain>These insights may aid in the development of therapeutic strategies to target IDH1-mutated <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
</text></document>